Advanced search
Publication Cover
Biotechnology & Biotechnological Equipment Volume 28, 2014 - Issue 4
Submit an article Journal homepage
777
Views
2
CrossRef citations to date
0
Altmetric
Article; Medical Biotechnology

Therapeutic approaches to the treatment of recurrent respiratory papillomatosis of the aerodigestive tract (a clinical study)

Toma AvramovII ENT Clinic, University Hospital “Tzaritsa Yoanna”, Sofia, BulgariaCorrespondence[email protected]
,
Evelina VetckovaBul-Bio-NCIPD Ltd., Sofia, Bulgaria
,
Maria NikolovaNational Reference Laboratory of Immunology, National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria
,
Dinko ValevBronchological Department, Specialized Hospital for Active Treatment of Pulmonary Diseases “St. Sofia” Ltd., Sofia, Bulgaria
,
Antoaneta ManolovaNational Center for Public Health and Analysis, Sofia, Bulgaria
,
Maya TafradgiiskaBronchological Department, Specialized Hospital for Active Treatment of Pulmonary Diseases “St. Sofia” Ltd., Sofia, Bulgaria
,
Dimitar KostadinovBronchological Department, Specialized Hospital for Active Treatment of Pulmonary Diseases “St. Sofia” Ltd., Sofia, Bulgaria
&
Ivan TchalacovII ENT Clinic, University Hospital “Tzaritsa Yoanna”, Sofia, Bulgaria
 show all
Pages 668-673 | Received 24 Apr 2014, Accepted 05 May 2014, Published online: 28 Oct 2014

References

  • Mackenzie M. Essays on growths in the larynx. London: J & A Churchill; 1871.
  • Draganov P, Todorov SP, Todorov I, Karchev T, Kalvatchev Z. Identification of HPV DNA in patients with juvenile-onset recurrent respiratory papillomatosis using SYBR Green real-time PCR. Int J Pediatr Otorhinolaryngol. 2006;70(3):469–473.
  • Todorov SP. Epidemiological specifications of the recurring respiratory papillomatosis in childhood years. Int Bull Otorhinolaryngol. 2009;2:31–32.
  • Todorov SP. Etiology of the recurring respiratory papillomatosis. Int Bull Otorhinolaryngol. 2009;2:33–35.
  • Lanzenberger-Schragl E, Donner A, Grasl MC, Zimpfer M, Aloy A. Superimposed high-frequency jet ventilation for laryngeal and tracheal surgery. Arch Otolaryngol Head Neck Surg. 2009;126(1):40–44.
  • Bourgain JL, Desruennes E, Fischler M, Ravussin P. Transtracheal high frequency jet ventilation for endoscopic airway surgery: a multicentre study. Br J Anaesth. 2009;87(6):870–875.
  • Chalakov IV, Avramov T, Valcheva S. Treatment of recurring respiratory papillomatosis type IІ of the larynx. Int Bull Otorhinolaryngol. 2010;1:43–44.
  • Chalakov IV, Avramov T, Kovachev T. CО2 laser surgery in otorhinolaryngology. Int Bull Otorhinolaryngol. 2011;3:19–22.
  • Ihra G, Hieber C, Adel S, Kashanipour A, Aloy A. Tubeless combined high-frequency jet ventilation for laryngotracheal laser surgery in paediatric anaesthesia. Acta Anaesthesiol Scand. 2000;44(4):475–479.
  • Goon P, Sonnex C, Jani P, Stanley M, Sudhoff H. Recurrent respiratory papillomatosis: an overview of current thinking and treatment. Eur Arch Otorhinolaryngol. 2008;265(2):147–151.
  • Rezaie-Majd JA, Bigenzahn W, Denk D-M, Burian M, Kornfehl J, Grasl MCH, Ihra G, Aloy A. Super imposed high-frequency jet ventilation (SHFJV) for endoscopic laryngotracheal surgery in more than 1500 patients. Br J Anaesth. 2006;96(5):650–659.
  • Avidano MA, Singleton GT. Adjuvant drug strategies in the treatment of recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg. 1995;112:197–202.
  • Chadha NK, James AL. Antiviral agents for the treatment of recurrent respiratory papillomatosis: a systematic review of the English-language literature. Otolaryngol Head Neck Surg. 2007;136(6):863–935.
  • Leventhal BG, Kashima HK, Weck PW, Mounts P, Whisnant JK, Clark KL, Cohen S, Dedo HH, Donovan DJ, Fearon BW. Randomized surgical adjuvant trial of interferon alfa-n1 in recurrent papillomatosis. Arch Otolaryngol Head Neck Surg. 1988;114:1163–1169.
  • Klebe S, Henderson DW. Facts and fiction: premalignant lesions of lung tissues. Pathology. 2013;45(3):305–315.
  • Nikolova M, Lelievre JD, Carriere M, Bensussan A, Lévy Y. Regulatory T cells modulate differentially the maturation and apoptosis of human CD8-T cell subsets. Blood. 2009;113(19):4556–4565.
  • Damyanov C, Terziev T, Koleva P, Chuchkova M. Combined immunochemotherapy (CEPM-VEP+BCG) in the treatment of invasive bladder tumors. Anticancer Drugs. 1994;5:298–304.
  • Conti-Freitas LC, Foss-Freitas MC, Mamede RC, Foss NT. Effect of BCG stimulus on proinflammatory cytokine production in laryngeal cancer. Cancer Immunol Immunother. 2009;58(1):25–29. doi: 10.1007/s00262-008-0520-7
  • Avramov T, Chalakov IV, Tcenova V. Preliminary observations on immunotherapy with the bacillus of Calmette–Guerin /BCG/ in papillomatosis of the respiratory tract. Int Bull Otorhinolaryngol. 2011;4:15–16.
  • Brandau S, Riemensberger J, Jacobsen M, Kemp D, Zhao W, Zhao X, Jocham D, Ratliff TL, Böhle A. NK cells are essential for effective BCG Immunotherapy. Int J Cancer. 2001;92:697–702.
  • Razack AH. Bacillus Calmette–Guerin and bladder cancer. Asian J Surg. 2007;30(4):302–309.
  • Shintani Y, Sawada Y, Inagaki T, Kohjimoto Y, Uekado Y, Shinka T. Intravesical instillation therapy with bacillus Calmette–Guerin for superficial bladder cancer: study of the mechanism of bacillus Calmette–Guerin immunotherapy. Int J Urol. 2007;14:140–146.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.